Ajanta Pharma Limited — Others, 09-12-2024: Loss of Share Certificates

Ajanta Pharma has reported that its Registrar and Transfer Agent has received a request from shareholder Mansi Gopal Shah for the issuance of a duplicate share certificate due to the loss of the original. The request involves 750 shares, with specific details provided. Following necessary due diligence, a "Letter of Confirmation" will be issued instead of a physical duplicate certificate. This development may have minimal immediate impact on the company’s financials, but it reflects ongoing shareholder activity, which could bolster trust among investors. Overall, it presents a neutral impact on investor sentiment.